Global sarcoma drug market is anticipated to grow at a CAGR of 8.3% during the forecast period (2024-2031). The rising FDA approvals for sarcoma drugs are a key factor driving the growth of the global sarcoma drugs market. For instance, in May 2022, Washington University School of Medicine developed an investigational drug to attack synovial sarcoma, a […]
